Anyone who has had chickenpox or the chickenpox vaccine is at risk for shingles.
Anyone who has had chickenpox or the chickenpox vaccine is at risk for the painful skin condition herpes zoster, more commonly known as shingles. Both diseases are caused by the varicella-zoster virus, which stays in the body after chickenpox clears and may reactivate later in life.
“The vast majority of the population has the potential to develop shingles,” says board-certified dermatologist Lorraine Rosamilia, MD, FAAD, a staff dermatologist at Geisinger Health System in State College, Pa. “Even if you don’t remember having chickenpox or getting a shot to prevent it, it’s likely the varicella-zoster virus is already in your body; if your immune system takes a nap, that virus can wake up, resulting in shingles.”
While shingles can affect anyone carrying the varicella-zoster virus, Rosamilia says, it’s more likely in people with weakened immune systems, including people older than 50. Fortunately for this population, the U.S. Food and Drug Administration has approved two vaccines to reduce the risk of shingles, one for adults older than 50 and another for adults older than 60.
“If you’re over 50 and have had chickenpox, talk to your doctor about getting a vaccine to help prevent shingles,” Rosamilia says. “And if you experience any shingles symptoms, no matter your age, see a doctor as soon as possible.”
The first warning sign of shingles is a burning or tingling sensation on a small area of skin, which can feel extremely sensitive. After a few days, the disease will progress into a painful rash, usually on one side of the face or body. The affected area also may develop fluid-filled blisters.
According to Rosamilia, early treatment not only can reduce the pain and severity of the disease, but also can help prevent potential side effects like eye problems, infection, and a condition called post-herpetic neuralgia, which causes pain, numbness, itching and tingling. Doctors may prescribe antiviral medication or painkillers to treat shingles, and patients also can relieve their symptoms by applying ice packs or cool, wet cloths; taking cool baths; applying calamine lotion; and wearing loose cotton clothing.
“In most cases, you don’t need to worry about being around someone with shingles,” Rosamilia says. “The disease may look contagious, and a lot of people think it is, but you can’t catch it from another person. Since it’s caused by the reactivation of a virus that’s already in your system, the only person you can catch it from is yourself.”
While shingles itself cannot spread from person to person, someone who has not had chickenpox or the vaccine could get chickenpox from direct contact with shingles blisters. Rosamilia recommends that people with shingles cover their rash with loose, sterile bandages and avoid contact with people for whom catching the virus could be dangerous, such as newborns, pregnant women who have never had chickenpox or the chickenpox vaccine, and those with weakened immune systems.
Source: American Academy of Dermatology
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.